Examining 3 major risk factors of AMD

Video

Joshua Mali, MD, discusses the three major risk factors for developing age-related macular degeneration (AMD).

Joshua Mali, MD, retina medical director, Macular Degeneration Association; vitreoretinal surgeon at The Eye Associates (Sarasota, FL); founder, CEO, Mali Enterprises, discusses the three major risk factors for developing age-related macular degeneration (AMD).

See more AMD Awareness content here, here, and here.

Recent Videos
3 experts are featured in this series.
3 experts are featured in this series.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Quan Dong Nguyen, MD, MSc, of the Byers Eye Institute at Stanford University School of Medicine, discusses his presentation on Stargardt disease at the American Academy of Ophthalmology meeting
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Related Content
Two elderly patients, a black woman and a white man, in a clinic support each other. Image credit: ©Seventyfour – stock.adobe.com

UK audit explores reasons patients skip diabetic retinopathy screenings

Lynda Charters
January 2nd 2025
Article

Investigators emphasised the need for continued efforts to raise awareness and support patients in attending regular screening

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

The number 2024 in big red-and-yellow text, on a backdrop of eye illustrations. Image created in Canva.

Ophthalmology Times wraps up a year of innovation and insight

Martin David Harp
December 30th 2024
Article

Highlights from the year, courtesy of our colleagues at Ophthalmology Times

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A person in a lab coat holds a test tube full of fluid. They enter data onto a laptop. Image credit: ©Parichat – stock.adobe.com

Finnish researchers report on registry data and changing workload resulting from anti-VEGF therapies

Lynda Charters
December 24th 2024
Article

The number of patients with retinal vascular diseases is expected to increase over time due to the aging population and lifestyle changes

A collage which shows many of the Ophthalmology Times Europe covers from 2024.

See the best of our print edition with the 2024 cover story roundup

Hattie Hayes
December 23rd 2024
Article

Our top 10 print stories highlight the core content concepts we explored this year

© 2025 MJH Life Sciences

All rights reserved.